title: Predictors of impaired renal function among HIV infected patients commencing highly active antiretroviral therapy in Jos, Nigeria.
abstract: BACKGROUND
  Kidney disease is a common complication of human immunodeficiency virus (HIV) infection even in the era of antiretroviral therapy, with kidney function being abnormal in up to 30% of HIV-infected patients. We determined the predictors of impaired renal function in HIV-infected adults initiating highly active antiretroviral therapy (HAART) in Nigeria.
  
  
  METHODS
  This was a retrospective study among HIV-1 infected patients attending the antiretroviral clinic at the Jos University Teaching Hospital (JUTH), between November 2005 and November 2007. Data were analysed for age, gender, weight, WHO clinical stage, CD4 count, HIV-1 RNA viral load, HBsAg and anti-HCV antibody status. Estimated glomerular filtration rate (eGFR) was calculated using the Cockcroft-Gault equation. Statistical analysis was done using Epi Info 3.5.1.
  
  
  RESULTS
  Data for 491 (294 females and 197 males) eligible patients were abstracted. The mean age of this population was 38.8±8.87 years. One hundred and seventeen patients (23.8%; 95% CI, 20.2-27.9%) had a reduced eGFR (defined as <60 mL/min), with more females than males (28.6% vs. 16.8%; P=0.02) having reduced eGFR. Age and female sex were found to have significant associations with reduced eGFR. Adjusted odds ratios were 1.07 (95% CI, 1.04, 1.10) and 1.96 (95% CI, 1.23, 3.12) for age and female sex, respectively.
  
  
  CONCLUSIONS
  Older age and female sex are independently associated with a higher likelihood of having lower eGFRs at initiation of HAART among our study population. We recommend assessment of renal function of HIV-infected patients prior to initiation of HAART to guide the choice and dosing of antiretroviral drugs.
authors.affiliation: Department of Medicine, HIV Clinic, Jos University Teaching Hospital, Jos, Nigeria.
authors.forename: Oche O
authors.initials: OO
authors.lastname: Agbaji
authors.forename: Adamu
authors.initials: A
authors.lastname: Onu
authors.forename: Patricia E
authors.initials: PE
authors.lastname: Agaba
authors.forename: Muhammad A
authors.initials: MA
authors.lastname: Muazu
authors.forename: Kakjing D
authors.initials: KD
authors.lastname: Falang
authors.forename: John A
authors.initials: JA
authors.lastname: Idoko
references.citation: Clin Infect Dis. 2005 Jun 1;40(11):1559-85
references.pmid: 15889353
references.citation: Hum Pathol. 1970 Dec;1(4):615-30
references.pmid: 5521735
references.citation: Kidney Int. 2002 Jan;61(1):195-202
references.pmid: 11786101
references.citation: Clin Nephrol. 2004 Jan;61(1):1-6
references.pmid: 14964451
references.citation: Kidney Int. 2006 Jun;69(12):2243-50
references.pmid: 16672914
references.citation: Clin Infect Dis. 2006 May 15;42(10):1488-95
references.pmid: 16619164
references.citation: Ann Intern Med. 2003 Jul 15;139(2):137-47
references.pmid: 12859163
references.citation: Nephron. 1976;16(1):31-41
references.pmid: 1244564
references.citation: Clin Infect Dis. 2004 Oct 15;39(8):1199-206
references.pmid: 15486845
references.citation: J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):203-9
references.pmid: 12571531
references.citation: AIDS. 2007 Oct 1;21(15):2101-3
references.pmid: 17885301
references.citation: AIDS. 2004 Nov 5;18(16):2171-8
references.pmid: 15577650
references.citation: Clin Infect Dis. 2008 Apr 15;46(8):1271-81
references.pmid: 18444867
references.citation: Kidney Int. 2006 May;69(10):1885-91
references.pmid: 16625149